A Pharmacist-Led, American Heart Association Heart360 Web-Enabled Home Blood Pressure Monitoring Program
A Pharmacist-Led, American Heart Association Heart360 Web-Enabled Home Blood Pressure Monitoring Program
复制标题
DOI：
10.1161/circoutcomes.112.968172
复制
发表时间：
2013-03-01
影响因子：
6.9
通讯作者：
Kroner, Beverly A.
中科院分区：
文献类型：
--
作者：
Magid, David J.;Olson, Kari L.;Kroner, Beverly A.
背景-为了确定是否药剂师领导的，心脏360启用，家庭血压监测（HBPM）干预改善血压（BP）控制相比，通常的护理（UC），方法和结果-这项随机对照试验进行了10凯萨永久科罗拉多诊所。总体而言，348例BP高于推荐水平的患者被随机分配至HBPM组（n=175）或UC组（n=173）。两组之间的基线特征无统计学显著性差异;然而，HBPM组的基线血压有高于UC组的趋势（收缩压为148.8与145.5 mm Hg;舒张压为89.6与88.0 mm Hg）。6个月时，HBPM组达到血压目标的患者比例（54.1%）显著高于UC组（35.4%; P
Background-To determine whether a pharmacist-led, Heart360-enabled, home blood pressure monitoring (HBPM) intervention improves blood pressure (BP) control compared with usual care (UC).Methods and Results-This randomized, controlled trial was conducted in 10 Kaiser Permanente Colorado clinics. Overall, 348 patients with BP above recommended levels were randomized to the HBPM (n=175) or UC (n=173) groups. There were no statistically significant differences in baseline characteristics between the groups; however, there was a trend toward a higher baseline BP for the HBPM group compared with the UC group (148.8 versus 145.5 mm Hg for systolic BP; 89.6 versus 88.0 mm Hg for diastolic BP). At 6 months, the proportion of patients achieving BP goal was significantly higher in the HBPM group (54.1%) than in the UC group (35.4%; P